beta-elemene

Small moleculeexperimental

Clinical trial activity

3 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0

Earliest trial started Apr 1, 2015 (NCT02629757)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • beta-elemene
  • beta-elemene
  • elemene
  • elemene
  • β-elemene
  • β-elemene

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03166553N/ANov 28, 2016Beijing Yijiayi Medicine Techonoloy Co., Ltd., Dalian Holley Kingkong Pharmaceutical Co., Ltd
NCT03167775N/ANov 28, 2016Beijing Yijiayi Medicine Techonoloy Co., Ltd., Dalian Holley Kingkong Pharmaceutical Co., Ltd
NCT02629757Phase 3Apr 1, 2015Sun Yat-Sen University
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Beijing Yijiayi Medicine Techonoloy Co., Ltd.For profit2212016
Dalian Holley Kingkong Pharmaceutical Co., LtdFor profit2012016
Sun Yat-Sen UniversityAcademic/Hospital1112015
3 organizations
Page 1 / 1